According to Transgene SA's latest financial reports the company's current EPS (TTM) is -$2.41. In 2022 the company made an earnings per share (EPS) of -$0.35 a decrease over its 2021 EPS that were of -$0.24.
Year | EPS | Change |
---|---|---|
2022 | -$0.35 | 48.16% |
2021 | -$0.24 | -6.93% |
2020 | -$0.26 | -0.6% |
2019 | -$0.26 | -273.41% |
2018 | $0.15 | -124.48% |
2017 | -$0.61 | 31.82% |
2016 | -$0.46 | -63.87% |
2015 | -$1.28 | -14.59% |
2014 | -$1.50 | -17.15% |
2013 | -$1.80 | 2.99% |
2012 | -$1.75 | 0.3% |
2011 | -$1.75 | 8.93% |
2010 | -$1.60 | -7.32% |
2009 | -$1.73 | 56.96% |
2008 | -$1.10 | 176.84% |
2007 | -$0.40 | -77.81% |
2006 | -$1.80 | -25.44% |
2005 (TTM) | -$2.41 | -19.09% |
2004 | -$2.98 | 18.71% |
2003 | -$2.51 | 35.08% |
2002 | -$1.86 | -16.55% |
2001 | -$2.22 | -37.1% |
2000 | -$3.54 | 13.45% |
1999 | -$3.12 | -60.26% |
1998 | -$7.84 | 109.21% |
1997 | -$3.75 |